ERβ Modulator Program

About Cadenza Bio

Cadenza Bio is a private, preclinical biotech leveraging a novel approach to targeting Estrogen Receptor β (ERβ) with oral small molecules. The company aims to move beyond symptom management in diseases like multiple sclerosis and endometriosis, seeking to halt progression and promote repair. Founded by experienced scientists and led by a lean team with strong advisory boards, Cadenza is positioned to address significant unmet needs in neuroinflammation and women's health. As a preclinical entity, its success hinges on advancing its lead candidates into clinical trials and securing substantial partnership or investment capital.

About Cadenza Bio

Cadenza Bio is a private, preclinical biotech leveraging a novel approach to targeting Estrogen Receptor β (ERβ) with oral small molecules. The company aims to move beyond symptom management in diseases like multiple sclerosis and endometriosis, seeking to halt progression and promote repair. Founded by experienced scientists and led by a lean team with strong advisory boards, Cadenza is positioned to address significant unmet needs in neuroinflammation and women's health. As a preclinical entity, its success hinges on advancing its lead candidates into clinical trials and securing substantial partnership or investment capital.

Therapeutic Areas

Other Multiple Sclerosis Drugs